Unknown

Dataset Information

0

Developing hypothetical inhibition mechanism of novel urea transporter B inhibitor.


ABSTRACT: Urea transporter B (UT-B) is a membrane channel protein that specifically transports urea. UT-B null mouse exhibited urea selective urine concentrating ability deficiency, which suggests the potential clinical applications of the UT-B inhibitors as novel diuretics. Primary high-throughput virtual screening (HTVS) of 50000 small-molecular drug-like compounds identified 2319 hit compounds. These 2319 compounds were screened by high-throughput screening using an erythrocyte osmotic lysis assay. Based on the pharmacological data, putative UT-B binding sites were identified by structure-based drug design and validated by ligand-based and QSAR model. Additionally, UT-B structural and functional characteristics under inhibitors treated and untreated conditions were simulated by molecular dynamics (MD). As the result, we identified four classes of compounds with UT-B inhibitory activity and predicted a human UT-B model, based on which computative binding sites were identified and validated. A novel potential mechanism of UT-B inhibitory activity was discovered by comparing UT-B from different species. Results suggest residue PHE198 in rat and mouse UT-B might block the inhibitor migration pathway. Inhibitory mechanisms of UT-B inhibitors and the functions of key residues in UT-B were proposed. The binding site analysis provides a structural basis for lead identification and optimization of UT-B inhibitors.

SUBMITTER: Li M 

PROVIDER: S-EPMC5376056 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Developing hypothetical inhibition mechanism of novel urea transporter B inhibitor.

Li Min M   Tou Weng Ieong WI   Zhou Hong H   Li Fei F   Ren Huiwen H   Chen Calvin Yu-Chian CY   Chen Calvin Yu-Chian CY   Yang Baoxue B  

Scientific reports 20140722


Urea transporter B (UT-B) is a membrane channel protein that specifically transports urea. UT-B null mouse exhibited urea selective urine concentrating ability deficiency, which suggests the potential clinical applications of the UT-B inhibitors as novel diuretics. Primary high-throughput virtual screening (HTVS) of 50000 small-molecular drug-like compounds identified 2319 hit compounds. These 2319 compounds were screened by high-throughput screening using an erythrocyte osmotic lysis assay. Bas  ...[more]

Similar Datasets

| S-EPMC3396522 | biostudies-literature
| S-EPMC7380188 | biostudies-literature
| S-EPMC7302978 | biostudies-literature
| S-EPMC3328751 | biostudies-literature
| S-EPMC5409228 | biostudies-literature
| S-EPMC4817154 | biostudies-literature
| S-EPMC7933130 | biostudies-literature
| S-EPMC5054527 | biostudies-literature
| S-EPMC8179158 | biostudies-literature
| S-EPMC7083837 | biostudies-literature